Original Article


Isorhamnetin inhibits progression of ovarian cancer by targeting ESR1

Manman Wang, Zhengtan Xu, Qi Cai, Yanmei Deng, Weiqiao Shi, Hongyu Zhou, Dajiang Wang, Jian Li

Download Citation